Cargando…
Possibilities and limitations of current technologies for quantification of biological extracellular vesicles and synthetic mimics
Nano-sized extracelullar vesicles (EVs) released by various cell types play important roles in a plethora of (patho)physiological processes and are increasingly recognized as biomarkers for disease. In addition, engineered EV and EV-inspired liposomes hold great potential as drug delivery systems. M...
Autores principales: | Maas, Sybren L.N., de Vrij, Jeroen, van der Vlist, Els J., Geragousian, Biaina, van Bloois, Louis, Mastrobattista, Enrico, Schiffelers, Raymond M., Wauben, Marca H.M., Broekman, Marike L.D., Nolte-'t Hoen, Esther N.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4324667/ https://www.ncbi.nlm.nih.gov/pubmed/25555362 http://dx.doi.org/10.1016/j.jconrel.2014.12.041 |
Ejemplares similares
-
CD4(+) T cell activation promotes the differential release of distinct populations of nanosized vesicles
por: van der Vlist, Els J., et al.
Publicado: (2012) -
Quantitative and qualitative flow cytometric analysis of nanosized cell-derived membrane vesicles
por: Hoen, Esther N.M. Nolte-'t, et al.
Publicado: (2012) -
Quantification and Size-profiling of Extracellular Vesicles Using Tunable Resistive Pulse Sensing
por: Maas, Sybren L. N., et al.
Publicado: (2014) -
Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients
por: Maas, Sybren L. N., et al.
Publicado: (2020) -
Nanocarrier-based drug combination therapy for glioblastoma
por: Zhao, Mengnan, et al.
Publicado: (2020)